Will I receive a placebo?
- If you qualify and agree to participate in the study, you will be assigned randomly to one of the two treatment groups, and neither you nor the study doctor will know which treatment you will be taking.
- In the Induction studies, there is a 1 in 3 chance you will receive a placebo, a pill that does not contain investigational medication but looks exactly like the investigational medication being tested.
- If your Crohn’s disease symptoms have improved after 12 weeks of treatment, you may have the option to participate in the maintenance study, in which you will receive either ozanimod or placebo depending on what you were randomized to receive in the Induction study.
- If your Crohn’s symptoms have not sufficiently improved after 12 weeks of treatment, you may have the option to enter an open-label extension study, in which you can receive ozanimod for up to 1 year.
Myth: Participation in a clinical research trial always means I may get no treatment at all.
Fact: If your Crohn’s symptoms have not sufficiently improved after 12 weeks of treatment, you may have the option to enter an open-label extension study, where you can receive ozanimod.
